{
    "Trade/Device Name(s)": [
        "HemosIL Routine Control Level 1",
        "HemosIL Routine Control Level 2",
        "HemosIL Routine Control Level 3"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K082857",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021023",
        "K021022",
        "K021024"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN"
    ],
    "Summary Letter Date": "December 19, 2008",
    "Summary Letter Received Date": "September 29, 2008",
    "Submission Date": "September 26, 2008",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose System for In Vitro Coagulation Studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)",
        "Activated Partial Thromboplastin Time (APTT)",
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACL 9000",
        "ACL Advance",
        "ACL 300",
        "ACL 6000"
    ],
    "Method(s)/Technology(ies)": [
        "Lyophilized plasma control"
    ],
    "Methodologies": [
        "Quality control of coagulation assays"
    ],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Routine Control Levels 1, 2, and 3 as lyophilized human plasma controls for coagulation assay quality control",
    "Indications for Use Summary": "For in vitro diagnostic use as quality control for coagulation assays including PT, APTT, and Fibrinogen on coagulation systems; Level 1 for normal range, Levels 2 and 3 for low and high abnormal ranges respectively",
    "fda_folder": "Hematology"
}